A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 EFFICACY STUDY OF AN AD26.RSV.PREF-BASED VACCINE IN THE PREVENTION OF LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV IN ADULTS AGED 60 YEARS AND OLDER
- Registry ID
- VAC18193RSV3001
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- JANSSEN VACCINES & PREVENTION B.V.
- Start date
- 2022-06-07
- Completion date
- 2023-03-29
- Last update
- 2021-07-23
Conditions
- LOWER RESPIRATORY TRACT INFECTION
Related clinical trials
- A PHASE 3, OBSERVER-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE NONINFERIORITY OF THE IMMUNE RESPONSE AND SAFETY OF THE RSVPREF3 OA INVESTIGATIONAL VACCINE IN ADULTS 50-59 YEARS OF AGE, INCLUDING ADULTS AT INCREASED RISK OF RESPIRATORY SYNCYTIAL VIRUS LOWER RESPIRATORY TRACT DISEASE, COMPARED TO OLDER ADULTS ¿60 YEARS OF AGE
- ASSESSMENT OF QBKPN SITE-SPECIFIC IMMUNOMODULATOR (SSI) EFFICACY IN IMPROVING INNATE IMMUNE FUNCTION AND REDUCING ALL-CAUSE RESPIRATORY TRACT INFECTION MORBIDITY IN ADULTS 65 YEARS OF AGE OR OLDER RESIDING IN THE COMMUNITY, IN INDEPENDENT-LIVING, ASSISTED-LIVING AND LONG-TERM CARE FACILITIES (RESILIENCE STUDY)
- A MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO DETERMINE IF RTB101 PREVENTS CLINICALLY SYMPTOMATIC RESPIRATORY ILLNESS IN THE ELDERLY
- A PHASE 2B, PARALLEL-GROUP, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF SYN-004 COMPARED TO PLACEBO FOR THE PREVENTION OF CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA IN PATIENTS WITH A DIAGNOSIS OF LOWER RESPIRATORY TRACT INFECTION
View on source registry